Insulet Corporation
(NASDAQ: PODD)

Insulet Corporation is engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. The OmniPod operates up to 72 hours (but no more than 80 hours) after it is activated.

243.460 -

-7.390 (-2.95%)
价格区间 242.290 - 254.395   (5%)
开盘 251.850
昨收 250.850
243.150
买盘 12
243.490
卖盘 1
成交量 304,472
成交额 54,624,745
注释 -
数据延迟。最后一次更新13 Feb 2026 01:20.
数据提供商
查看所有活动

关于 Insulet

Insulet Corporation is engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. The OmniPod operates up to 72 hours (but no more than 80 hours) after it is activated.

Loading Chart...

Please login to view stock data and analysis